The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
Emerging evidences demonstrate the involvement of gut microbiota in the progression of chronic kidney disease (CKD) and CKD-associated complications including cardiovascular disease (CVD) and intestinal dysfunction. In this review, we discuss the interactions between the gut, kidney and heart in CKD...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-03-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.837500/full |
| _version_ | 1828898648789876736 |
|---|---|
| author | Yinghui Huang Wang Xin Jiachuan Xiong Mengying Yao Bo Zhang Jinghong Zhao |
| author_facet | Yinghui Huang Wang Xin Jiachuan Xiong Mengying Yao Bo Zhang Jinghong Zhao |
| author_sort | Yinghui Huang |
| collection | DOAJ |
| description | Emerging evidences demonstrate the involvement of gut microbiota in the progression of chronic kidney disease (CKD) and CKD-associated complications including cardiovascular disease (CVD) and intestinal dysfunction. In this review, we discuss the interactions between the gut, kidney and heart in CKD state, and elucidate the significant role of intestinal microbiota in the gut-kidney-heart axis hypothesis for the pathophysiological mechanisms of these diseases, during which process mitochondria may serve as a potential therapeutic target. Dysregulation of this axis will lead to a vicious circle, contributing to CKD progression. Recent studies suggest novel therapies targeting gut microbiota in the gut-kidney-heart axis, including dietary intervention, probiotics, prebiotics, genetically engineered bacteria, fecal microbiota transplantation, bacterial metabolites modulation, antibiotics, conventional drugs and traditional Chinese medicine. Further, the identification of specific microbial communities and their corresponding pathophysiological metabolites and the illumination of the gut-kidney-heart axis may contribute to innovative basic research, clinical trials and therapeutic strategies against CKD progression and uremic complications in CKD patients. |
| first_indexed | 2024-12-13T15:20:11Z |
| format | Article |
| id | doaj.art-4aaa87faa075482dab363e89be263dc4 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-12-13T15:20:11Z |
| publishDate | 2022-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-4aaa87faa075482dab363e89be263dc42022-12-21T23:40:36ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-03-011310.3389/fphar.2022.837500837500The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney DiseaseYinghui HuangWang XinJiachuan XiongMengying YaoBo ZhangJinghong ZhaoEmerging evidences demonstrate the involvement of gut microbiota in the progression of chronic kidney disease (CKD) and CKD-associated complications including cardiovascular disease (CVD) and intestinal dysfunction. In this review, we discuss the interactions between the gut, kidney and heart in CKD state, and elucidate the significant role of intestinal microbiota in the gut-kidney-heart axis hypothesis for the pathophysiological mechanisms of these diseases, during which process mitochondria may serve as a potential therapeutic target. Dysregulation of this axis will lead to a vicious circle, contributing to CKD progression. Recent studies suggest novel therapies targeting gut microbiota in the gut-kidney-heart axis, including dietary intervention, probiotics, prebiotics, genetically engineered bacteria, fecal microbiota transplantation, bacterial metabolites modulation, antibiotics, conventional drugs and traditional Chinese medicine. Further, the identification of specific microbial communities and their corresponding pathophysiological metabolites and the illumination of the gut-kidney-heart axis may contribute to innovative basic research, clinical trials and therapeutic strategies against CKD progression and uremic complications in CKD patients.https://www.frontiersin.org/articles/10.3389/fphar.2022.837500/fullgut microbiotagut-kidney-heart axischronic kidney diseasecardiovascular diseaseintestinal dysfunction |
| spellingShingle | Yinghui Huang Wang Xin Jiachuan Xiong Mengying Yao Bo Zhang Jinghong Zhao The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease Frontiers in Pharmacology gut microbiota gut-kidney-heart axis chronic kidney disease cardiovascular disease intestinal dysfunction |
| title | The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease |
| title_full | The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease |
| title_fullStr | The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease |
| title_full_unstemmed | The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease |
| title_short | The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease |
| title_sort | intestinal microbiota and metabolites in the gut kidney heart axis of chronic kidney disease |
| topic | gut microbiota gut-kidney-heart axis chronic kidney disease cardiovascular disease intestinal dysfunction |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2022.837500/full |
| work_keys_str_mv | AT yinghuihuang theintestinalmicrobiotaandmetabolitesinthegutkidneyheartaxisofchronickidneydisease AT wangxin theintestinalmicrobiotaandmetabolitesinthegutkidneyheartaxisofchronickidneydisease AT jiachuanxiong theintestinalmicrobiotaandmetabolitesinthegutkidneyheartaxisofchronickidneydisease AT mengyingyao theintestinalmicrobiotaandmetabolitesinthegutkidneyheartaxisofchronickidneydisease AT bozhang theintestinalmicrobiotaandmetabolitesinthegutkidneyheartaxisofchronickidneydisease AT jinghongzhao theintestinalmicrobiotaandmetabolitesinthegutkidneyheartaxisofchronickidneydisease AT yinghuihuang intestinalmicrobiotaandmetabolitesinthegutkidneyheartaxisofchronickidneydisease AT wangxin intestinalmicrobiotaandmetabolitesinthegutkidneyheartaxisofchronickidneydisease AT jiachuanxiong intestinalmicrobiotaandmetabolitesinthegutkidneyheartaxisofchronickidneydisease AT mengyingyao intestinalmicrobiotaandmetabolitesinthegutkidneyheartaxisofchronickidneydisease AT bozhang intestinalmicrobiotaandmetabolitesinthegutkidneyheartaxisofchronickidneydisease AT jinghongzhao intestinalmicrobiotaandmetabolitesinthegutkidneyheartaxisofchronickidneydisease |